Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
22
LU Quote, Financials, Valuation and Earnings
Last price:
$2.47
Seasonality move
:
-0.32%
Day range:
$2.39 - $2.49
52-week range:
$2.00 - $4.94
Dividend yield:
0%
P/E ratio:
357.53x
P/S ratio:
0.55x
P/B ratio:
0.18x
Volume:
4.7M
Avg. volume:
3.5M
1-year change:
-11.83%
Market cap:
$2.1B
Revenue:
$4B
EPS (TTM):
-$0.77
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $5.9B | $6.5B | $8.5B | $7.4B | $4B | |
| Revenue Growth (YoY) | 10.89% | 9.99% | 30.28% | -12.32% | -46.4% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $2.9B | $3B | $3.3B | $2.8B | $1.7B | |
| Other Inc / (Exp) | $55.6M | $85.7M | $66M | $81.7M | $129.6M | |
| Operating Expenses | $2.8B | $2.8B | $3.2B | $2.7B | $1.7B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $2.8B | $2.6B | $3.6B | $1.9B | $232.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $885.5M | $816.3M | $1B | $631M | $86.3M | |
| Net Income to Company | $2.8B | $2.6B | $3.6B | $1.9B | $232.6M | |
| Minority Interest in Earnings | $2.2M | $11.3M | $14.8M | -$11.3M | -$20.9M | |
| Net Income to Common Excl Extra Items | $1.9B | $1.8B | $2.6B | $1.3B | $125.4M | |
| Basic EPS (Cont. Ops) | $3.55 | $3.24 | $4.40 | $2.26 | $0.22 | |
| Diluted EPS (Cont. Ops) | $3.55 | $3.22 | $4.14 | $2.26 | $0.22 | |
| Weighted Average Basic Share | $543.3M | $552.1M | $590.9M | $572.5M | $573.1M | |
| Weighted Average Diluted Share | $543.3M | $563M | $679.9M | $573.7M | $573.6M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $3.2B | $3.5B | $5.2B | $3.9B | $1.5B | |
| Revenue (Reported) | $5.9B | $6.5B | $8.5B | $7.4B | $4B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $3.2B | $3.5B | $5.2B | $3.9B | $1.5B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $1.4B | $2.2B | $1.6B | $902.9M | $612.8M | |
| Revenue Growth (YoY) | -1.09% | 53.72% | -24.3% | -45.21% | -32.13% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $784.6M | $937.3M | $680.7M | $385.6M | $225.6M | |
| Other Inc / (Exp) | $15.5M | $41.1M | $24.5M | $34.9M | $10.2M | |
| Operating Expenses | $784.6M | $874.1M | $670.8M | $385.6M | $225.6M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $523M | $924.7M | $308.2M | $41.9M | -$100.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $211.5M | $289.2M | $110.4M | $23.8M | $963.4K | |
| Net Income to Company | -- | $2.9B | -- | -- | -- | |
| Minority Interest in Earnings | $3.9M | $2.1M | -$4.1M | -$5.1M | -$20.9M | |
| Net Income to Common Excl Extra Items | $315.5M | $637.6M | $193.7M | $13M | -$122.2M | |
| Basic EPS (Cont. Ops) | $0.52 | $1.08 | $0.34 | $0.02 | -$0.16 | |
| Diluted EPS (Cont. Ops) | $0.52 | $1.02 | $0.34 | $0.02 | -$0.16 | |
| Weighted Average Basic Share | $609.8M | $588.2M | $571.9M | $586.1M | $781.1M | |
| Weighted Average Diluted Share | $609.8M | $623.8M | $571.9M | $586.1M | $781.1M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $761.7M | $950.6M | $352.8M | $47.4M | -$92M | |
| Revenue (Reported) | $1.4B | $2.2B | $1.6B | $902.9M | $612.8M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $761.7M | $950.6M | $352.8M | $47.4M | -$92M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $6.1B | $8.2B | $8.3B | $4.5B | $2.8B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $3.1B | $3.3B | $2.8B | $2B | $1.1B | |
| Other Inc / (Exp) | $103.5M | $127.9M | $155.9M | $30.9M | $91.7M | |
| Operating Expenses | $3.1B | $3.1B | $2.6B | $2B | $1.1B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $2.6B | $3.6B | $2.8B | $307.4M | -$239.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $894.7M | $1B | $843.3M | $152.3M | $195M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | $6M | $19.1M | -$8.4M | -$20.7M | -$36.8M | |
| Net Income to Common Excl Extra Items | $1.7B | $2.6B | $1.9B | $134.3M | -$471.2M | |
| Basic EPS (Cont. Ops) | $3.04 | $4.36 | $4.74 | $0.40 | -$0.77 | |
| Diluted EPS (Cont. Ops) | $3.04 | $4.13 | $4.48 | $0.40 | -$0.77 | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $3.2B | $4.2B | $3.4B | $2.1B | $1.4B | |
| Revenue (Reported) | $6.1B | $8.2B | $8.3B | $4.5B | $2.8B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $3.2B | $4.2B | $3.4B | $2.1B | $1.4B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $4.5B | $6.3B | $6.1B | $3.2B | $2B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $2.3B | $2.7B | $2.1B | $1.4B | $766.9M | |
| Other Inc / (Exp) | $79M | $122.3M | $157.7M | $98.7M | $61.3M | |
| Operating Expenses | $2.3B | $2.6B | $2.1B | $1.4B | $766.9M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $2B | $2.9B | $2.1B | $392.2M | -$88.5M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $614.9M | $810.4M | $617.7M | $123.9M | $230.3M | |
| Net Income to Company | -- | $2.9B | -- | -- | -- | |
| Minority Interest in Earnings | $5.6M | $13.2M | -$10M | -$19.4M | -$35.2M | |
| Net Income to Common Excl Extra Items | $1.4B | $2.1B | $1.5B | $248.9M | -$354M | |
| Basic EPS (Cont. Ops) | $2.41 | $3.61 | $3.96 | $0.60 | -$0.56 | |
| Diluted EPS (Cont. Ops) | $2.41 | $3.38 | $3.72 | $0.60 | -$0.56 | |
| Weighted Average Basic Share | $1.7B | $1.8B | $1.7B | $1.7B | $1.9B | |
| Weighted Average Diluted Share | $1.7B | $1.9B | $1.8B | $1.7B | $1.9B | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $2.3B | $3.1B | $2.2B | $444.6M | $290.5M | |
| Revenue (Reported) | $4.5B | $6.3B | $6.1B | $3.2B | $2B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $2.3B | $3.1B | $2.2B | $444.6M | $290.5M | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $1.1B | $3.8B | $5.5B | $6.4B | $5.6B | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $2.3B | $2.4B | $2.1B | $1.2B | $571.9M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | $22.8M | $104.8M | $115.9M | $98.5M | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $3.4B | $6.3B | $9B | $8.2B | $6.5B | |
| Property Plant And Equipment | $204.7M | $213.9M | $185.9M | $156M | $82M | |
| Long-Term Investments | $4B | $6.3B | $5.5B | $4.9B | $4.5B | |
| Goodwill | $1.3B | $1.4B | $1.4B | $1.3B | $1.3B | |
| Other Intangibles | $271.1M | $288.1M | $141.1M | $128.3M | $123.4M | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $21.4B | $38.1B | $56.5B | $50.6B | $33.4B | |
| Accounts Payable | $75.2M | $66.3M | $62.9M | $28M | $19.6M | |
| Accrued Expenses | $303.3M | $315.7M | $341M | $777.5M | $159.1M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $10.1B | $19.8B | $33.9B | $27.7B | $12.8B | |
| Long-Term Debt | $1.9B | $4.3B | $6.9B | $7.6B | $6.3B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $14.5B | $25.4B | $41.7B | $36.9B | $20.2B | |
| Common Stock | $9.9K | $11.8K | $11.8K | $10.9K | $10.6K | |
| Other Common Equity Adj | $654.9M | $1.1B | $1.5B | $312.8M | $22M | |
| Common Equity | $6.9B | $12.5B | $14.6B | $13.5B | $13B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $14.8M | $243.6M | $236.2M | $231.4M | $217.4M | |
| Total Equity | $6.9B | $12.7B | $14.8B | $13.7B | $13.2B | |
| Total Liabilities and Equity | $21.4B | $38.1B | $56.5B | $50.6B | $33.4B | |
| Cash and Short Terms | $1.1B | $3.8B | $5.5B | $6.4B | $5.6B | |
| Total Debt | $1.9B | $4.3B | $6.9B | $7.6B | $6.3B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $2.1B | $4.7B | $6.5B | $5.5B | $3.9B | |
| Short Term Investments | -- | -- | -- | -- | $182.7M | |
| Accounts Receivable, Net | $3.6B | $3.4B | $1.4B | $1.3B | $646.8M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | $34.4M | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $6B | $9B | $8.5B | $6.7B | $4.7B | |
| Property Plant And Equipment | $215.8M | $179.1M | $151.4M | $92.5M | $65.8M | |
| Long-Term Investments | $5B | $6.1B | $4.3B | $3.9B | $4.9B | |
| Goodwill | $1.3B | $1.4B | $1.3B | $1.2B | $1.3B | |
| Other Intangibles | $275.7M | $245M | $125.2M | $120.2M | $141M | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $30.7B | $51.6B | $52B | $35.5B | $29.4B | |
| Accounts Payable | $912.4M | $1.1B | $24.9M | $1.1B | $862.7M | |
| Accrued Expenses | -- | -- | $271.2M | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $16B | $29.7B | $29.1B | $15.8B | $9B | |
| Long-Term Debt | $4.3B | $6B | $8.2B | $5.8B | $6.7B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $21.8B | $37.2B | $38.7B | $22.6B | $17.1B | |
| Common Stock | $10.1K | $11.6K | $10.5K | $10.3K | $16.7K | |
| Other Common Equity Adj | $939.9M | $1.2B | $1.1B | -$4.3M | $30.6M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $238.7M | $233M | $222.8M | $209.7M | $255.7M | |
| Total Equity | $8.9B | $14.4B | $13.3B | $12.9B | $12.3B | |
| Total Liabilities and Equity | $30.7B | $51.6B | $52B | $35.5B | $29.4B | |
| Cash and Short Terms | $2.1B | $4.7B | $6.5B | $5.5B | $4B | |
| Total Debt | $4.3B | $6B | $8.2B | $5.8B | $6.7B | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $2.8B | $2.6B | $3.6B | $1.9B | $232.6M | |
| Depreciation & Amoritzation | $118.3M | $125M | $127.7M | $114.8M | $85.7M | |
| Stock-Based Compensation | -$8M | $23.9M | $20.7M | $6.8M | -$5.1M | |
| Change in Accounts Receivable | -$5B | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $317.3M | $1B | $772.5M | $663.3M | $2.1B | |
| Capital Expenditures | $26.3M | $29.9M | $23.7M | $18.3M | $6.8M | |
| Cash Acquisitions | -$248.9M | -$5.8M | -- | -- | $3.5M | |
| Cash From Investing | -$1.6B | -$2.2B | $48.6M | $1.3B | -$839.4M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -$1.1B | -$202.9M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $650.4M | $1.5B | $1.1B | $1.3B | $2.1B | |
| Long-Term Debt Repaid | -$1.1B | -$503.1M | -$381.8M | -$1.5B | -$4.6B | |
| Repurchase of Common Stock | -- | -- | -$997.2M | -- | -- | |
| Other Financing Activities | -- | -- | -$733.4K | -- | -$28.2M | |
| Cash From Financing | -$378.2M | $3.6B | -$379.1M | -$1.5B | -$2.9B | |
| Beginning Cash (CF) | $2.7B | $1.1B | $3.7B | $3.9B | $4.2B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$1.7B | $2.5B | $441.9M | $444.3M | -$1.6B | |
| Ending Cash (CF) | $1.1B | $3.4B | $4.1B | $4.4B | $2.6B | |
| Levered Free Cash Flow | $291M | $1B | $748.8M | $645M | $2.1B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | $2.9B | -- | -- | -- | |
| Depreciation & Amoritzation | -- | $94.9M | -- | -- | -- | |
| Stock-Based Compensation | -- | $15.7M | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $740.7M | $263.1M | $360.3M | $675.1M | $72.6M | |
| Capital Expenditures | -- | $10.3M | -$6.6M | -$3.4M | -$3M | |
| Cash Acquisitions | -- | -- | -- | -$3.7M | $99.6M | |
| Cash From Investing | -$1.4B | $397.6M | -$880.1M | -$521.2M | -$259.9M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | $747.9M | $112.2M | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | $916M | -$410.4M | -$1.1B | -$819.8M | |
| Long-Term Debt Repaid | -- | -$268.1M | $746.1M | $2.6B | $1.4B | |
| Repurchase of Common Stock | -- | -$698.7M | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -$93.5M | -- | |
| Cash From Financing | $462.2M | -$479.9M | $689.6M | -$1.1B | -$1.3B | |
| Beginning Cash (CF) | $2.1B | $3.8B | $4.4B | $3.6B | $2.8B | |
| Foreign Exchange Rate Adjustment | $28.4M | $2.7M | $29.7M | $8.8M | -$13.2M | |
| Additions / Reductions | -$164.4M | $180.9M | $169.7M | -$906.8M | -$1.4B | |
| Ending Cash (CF) | $2B | $4B | $4.5B | $2.6B | $1.4B | |
| Levered Free Cash Flow | $740.7M | $252.9M | $366.9M | $678.5M | $75.5M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | $15.7M | $5M | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | $527.3M | -$148.7M | $2.1B | $1.3B | |
| Capital Expenditures | -- | $10.3M | $13.4M | $18.3M | $6.8M | |
| Cash Acquisitions | -- | -- | -- | -- | $3.5M | |
| Cash From Investing | -- | -$1.2B | $1.5B | -$79.6M | -$489.3M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -$1.1B | -$202.9M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | $2.5B | -$668.2M | -$3.8B | -$2B | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | $1.9B | $716.7M | -$1.7B | -$1.3B | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | $527.3M | -$162.1M | $2.1B | $1.2B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | $2.9B | -- | -- | -- | |
| Depreciation & Amoritzation | -- | $94.9M | -- | -- | -- | |
| Stock-Based Compensation | -- | $15.7M | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $1.4B | $867.3M | -$53.8M | $1.4B | $559.2M | |
| Capital Expenditures | -- | $10.3M | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$1.4B | -$407M | $1.1B | -$259.3M | $90.7M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | $2.4M | |
| Long-Term Debt Issued | -- | $916M | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -$268.1M | -- | -- | -- | |
| Repurchase of Common Stock | -- | -$698.7M | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $990.2M | -$126.1M | -$415.1M | -$2.7B | -$1.8B | |
| Beginning Cash (CF) | $4.4B | $11.1B | $13.5B | $12.7B | $8.5B | |
| Foreign Exchange Rate Adjustment | $27.1M | -$6.8M | $30.1M | $69.8M | -$1.3M | |
| Additions / Reductions | $942.8M | $334.3M | $609.1M | -$1.5B | -$1.2B | |
| Ending Cash (CF) | $5.4B | $11.5B | $13.8B | $10.9B | $7.3B | |
| Levered Free Cash Flow | $1.4B | $857.1M | -$53.8M | $1.4B | $559.2M | |
Get LU Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
LU
Sector
P/E ratio
357.53x
12.02x
PEG ratio
--
0.36x
P/B ratio
0.18x
1.05x
Price / LTM sales
0.55x
2.55x
Growth Metrics
LU
Sector
Revenue growth
-32.13%
6.08%
Earnings growth
--
6.45%
Revenue (5-year growth)
-5.67%
5.85%
Earnings forecast
$0.07
$0.56
Profitability
LU
Sector
Profitability FY 2024
--
$179.9M
Return on invested capital
-2.48%
5.27%
Return on assets
-1.47%
0.98%
Return on equity
-3.75%
9.43%
Earnings Date
Last Earnings Date
Oct
21
Next Earnings Date
Mar
21
Estimated Next Earnings Date
Jan
20
Balance Sheet
LU
Sector
Total cash
$4B
$617M
Short term investments
--
$408.4M
Total assets
$33.4B
$4.5B
Long term debt
$6.7B
$270.8M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 23
Quantum [QMCO] is up 3.25% over the past day.
Sell
46
NUKK alert for Dec 23
Nukkleus [NUKK] is up 6.6% over the past day.
Sell
1
IIPR alert for Dec 23
Innovative Industrial Properties [IIPR] is down 5.78% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
